The Brazilian beauty giant reported 8.8% growth in The Body Shop sales in the fiscal 2019 first half, driven by strong gains in the UK and other key markets, offsetting the effect of 37 store closures in the past year as part of Natura’s transformation plan for the business. Meanwhile, incoming acquiree Avon is seeing better productivity, though sales continued to fall in the firm’s second quarter.
Natura & Co. doubled net income and posted strong growth across its three major businesses in the fiscal 2019 second quarter as it looks forward to wrapping its acquisition of [Avon Products Inc.], expected in the first quarter of the new fiscal year.
The Body Shop, acquired from L'Oreal SA in September 2017, achieved 7.5% growth in the quarter, reported, contributing R$867.5bn...
Following Energy and Commerce Health Subcommittee hearing about FDA’s human food and tobacco programs on 10 September, gap between what the trade groups, committee leadership and the FDA each want more of doesn’t appear to be shrinking.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Global beauty giant is working to adapt its approach to the prestige market to meet escalating competition, increased points of sale, and more knowledgeable consumers with new shopping habits, CFO Tracey Travis said at the Barclays Global Consumer Staples Conference.
The gut’s microbiome will shape future medical advances, offering personalized therapies and prevention strategies for a wide range of diseases.
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
